01453oam 2200421 450 991070736480332120160715104828.0(CKB)5470000002463869(OCoLC)953619798(OCoLC)995470000002463869(EXLCZ)99547000000246386920160715d1990 ua 0engurmn|||||||||rdacontentrdamediardacarrierPerspectives of drug manufacturers investigational new drug and new drug applications[Washington, D.C.] :Department of Health and Human Services, Office of Inspector General, Office of Evaluation and Inspections,1990.1 online resource (24 unnumbered pages) illustrationsTitle from title screen (viewed July 14, 2016)."February 1990.""OEI-12-90-00771."Includes bibliographical references (page 14).Perspectives of drug manufacturers Pharmaceutical policyUnited StatesDrug approvalUnited StatesPharmaceutical industryUnited StatesPharmaceutical policyDrug approvalPharmaceutical industryGPOGPOGPOBOOK9910707364803321Perspectives of drug manufacturers3487044UNINA